Advertisements



Bristol-Myers can be "a sweet pill" for investors, Barron"s says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 12th, 2019

Why Bristol-Myers Squibb Can Be a Sweet Pill for Investors

Wall Street has soured on the deal for Celgene, but Bristol-Myers has one of the lowest valuations in the drug sector and could itself become a takeover target.....»»

Category: topSource: barronsJan 13th, 2019

Starboard no longer urging investors to vote against Bristol-Celgene deal

Activist hedge fund Starboard Value LP said on Friday it will no longer urge shareholders to oppose Bristol-Myers Squibb Co's plans to buy Celgene Corp, even though it thinks the deal is too risky and will vote its own shares against it......»»

Category: topSource: reutersMar 29th, 2019

Celgene"s stock surges, after Starboard withdraws proxy fight of Bristol-Myers buyout deal

Shares of Celgene Corp. shot up 7.5% in very active midday trade Friday, after activist investors Starboard Value LP said it would no longer oppose the Bristol-Myers.....»»

Category: topSource: marketwatchMar 29th, 2019

Is Bristol Myers Squibb Company (BMY) A Good Stock To Buy?

The government requires hedge funds and wealthy investors that crossed the $100 million equity holdings threshold are required to file a.....»»

Category: topSource: insidermonkeyMar 26th, 2019

Is Bristol-Myers (BMY) a Solid Pick for Value Investors?

Let's see if Bristol-Myers (BMY) stock is a good choice for value-oriented investors right now from multiple angles. Want the latest recommendations from Zacks Inve.....»»

Category: dealsSource: nytMar 11th, 2019

Here"s What Starboard Might Be Planning for Papa John"s and Bristol-Myers

The hedge fund has a history in both restaurants and in health care. It isn’t clear what Starboard CEO Jeff Smith plans this time, but investors should take note......»»

Category: topSource: barronsFeb 5th, 2019

Barron"s Picks And Pans: Amazon, Apple, Bristol-Myers, Starbucks And More

This weekend's Barron's cover story reveals the results of the Barron's 2019 Investment Roundtable. Other featured articles examine safe dividend growth stocks and the best stock funds for risky markets. read more.....»»

Category: blogSource: benzingaJan 13th, 2019

Should Investors Like Bristol-Myers" Buyout of Celgene?

The pharmaceutical giant’s $74 billion bid for the biotechnology player sent the acquirer’s shares significantly lower, but that’s hardly unusual......»»

Category: topSource: foxnewsJan 7th, 2019

Celgene Investors Should Take the Money and Run

With Celgene stock trading 25% higher after Bristol-Myers Squibb made a $74 billion acquisition offer, Celgene investors probably shouldn’t wait around to see if the deal closes......»»

Category: topSource: barronsJan 4th, 2019

Celgene shareholders should sell now, Leerink says

Bristol-Myers Squibb Co.'s agreement to acquire Celgene Corp. is "an exit opportunity for Celgene shareholders," Leerink analysts wrote in a note to investors Thur.....»»

Category: topSource: marketwatchJan 3rd, 2019

Merck profit beats, but Keytruda sales fail to impress

Merck & Co beat quarterly profit estimates on Friday as sales of its blockbuster drug Keytruda overtook rival Bristol-Myers Squibb's Opdivo, but that was not enough for investors who expected bigger gains in market share for the cancer therapy......»»

Category: topSource: reutersJul 27th, 2018

Merck Cements Lead in Lung Cancer as Bristol-Myers Fizzles

Merck & Co. might have just shut the door on rival Bristol-Myers Squibb Co. as investors weigh new data that could reshape the treatment of lung cancer, by far the deadliest form of cancer in the U.S......»»

Category: topSource: moneycentralApr 16th, 2018

Financial Advantage, Inc. Buys The Walt Disney Co, Celgene Corp, Bristol-Myers Squibb Company, ...

Related Stocks: DIS, HBI, COP, CELG, BMY, SYK, INTU, GMRE, PYPL, FOXA, GE,.....»»

Category: smallbizSource: nytApr 17th, 2019

Bristol-Myers" Shareholders Vote for Celgene Acquisition

Bristol-Myers' (BMY) gets a green signal from a majority of its shareholders for the merger with.....»»

Category: personnelSource: nytApr 15th, 2019

Stocks That Fell to 3-Year Lows in the Week of April 12

Bristol-Myers Squibb Co., Annaly Capital Management Inc., Newell Brands Inc. and Mylan NV have declined to their respective three-year lowsRelated Stocks: BMY, NLY, NWL, MYL,.....»»

Category: blogSource: gurufocusApr 14th, 2019

Barron"s On: CVS As The Front Door To Health Care

This weekend's Barron's cover story examines the company aiming to give consumers more power over their health care. Is this the time for investors to jump in or to take a wait and see attitude? read more.....»»

Category: blogSource: benzingaApr 13th, 2019

Bristol-Myers CEO: We"re "one step closer to creating that great company" with Celgene

Celgene brings to Bristol-Myers five late-stage products that could be approved in the near term, Caforio said......»»

Category: topSource: madmoneyApr 12th, 2019

Bristol-Myers says Celgene deal on track for Q3 close after shareholder approval

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 12th, 2019

Celgene stockholders vote to approve acquisition by Bristol-Myers

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 12th, 2019

Bristol-Myers says 75% of holders voted for Celgene deal, Bloomberg reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 12th, 2019